After a rough 2021 that featured the Evergrande Crisis and heavy regulatory measures on technology to keep monopolistic moves in check, investors are eyeing opportunities in China. One of the sectors of interest is the biotech sector. Under the broad scope of healthcare in general, pharmaceuticals are seeing exponential growth, which should also flow over [...] The post Capitalize on Biotech Growth in China With This ETF appeared first on ETF Trends .